Template:Ramipril: Difference between revisions

Latest revision as of 14:29, 25 April 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2], Amr Marawan, M.D. [3]

For patient information about Ramipril, click here.

Ramipril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{SB}} ALTACE<sup>®</sup> Prilace<sup>®</sup>  Ramipro<sup>®</sup>  Tritace<sup>®</sup> Altace<sup>®</sup>  Ramitens<sup>®</sup>  Ampril<sup>®</sup>  Corpril<sup>®</sup>  Piramil<sup>®</sup>  Prilinda<sup>®</sup> Ramace<sup>®</sup> Altace<sup>®</sup> <ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ALTACE (RAMIPRIL) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fc34cd8-86e6-4034-73bd-4263a68ba046 | publisher =  | date =  | accessdate = }}</ref>
+{{CMG}}; {{AE}} {{AZ}}, {{AM}}
-{{Ramipril}}
-==References==
+'''''For patient information about Ramipril, click [[Ramipril (patient information)|here]].'''''
-{{Reflist|2}}
+===Ramipril===
-[[Category:Cardiovascular Drugs]]
+* [[Ramipril tablet]]
-[[Category:Drugs]]
+==Overview==
+'''Ramipril''' tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of [[hypertension]], [[heart failure]], left ventricular dysfunction after [[myocardial infarction]], [[diabetic nephropathy]]. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. [[hypotension]], [[rash]], [[hyperkalemia]], disorder of taste, [[cough]].
+==Category==
+Antihypertensive Agents, Angiotensin Converting Enzyme Inhibitors.